Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common Cancers.

ABSTRACT:

Importance

Resource limitations because of pandemic or other stresses on infrastructure necessitate the triage of time-sensitive care, including cancer treatments. Optimal time to treatment is underexplored, so recommendations for which cancer treatments can be deferred are often based on expert opinion.

Objective

To evaluate the association between increased time to definitive therapy and mortality as a function of cancer type and stage for the 4 most prevalent cancers in the US.

Design, setting, and participants

This cohort study assessed treatment and outcome information from patients with nonmetastatic breast, prostate, non-small cell lung (NSCLC), and colon cancers from 2004 to 2015, with data analyzed January to March 2020. Data on outcomes associated with appro

SUBMITTER: Cone EB 

PROVIDER: S-EPMC7737088 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature